MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could fewer radiation sessions be just as effective for bladder cancer?
Disease control Recruiting nowThis study compares a standard course of radiation therapy (given over several weeks) with a much shorter course (just a few treatments) for people with muscle invasive bladder cancer. Both groups also receive chemotherapy. The goal is to see if the shorter radiation schedule wor…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
Blood test may tell who needs extra cancer treatment after bladder surgery
Disease control Recruiting nowThis study looks at whether a simple blood test can find leftover cancer DNA after bladder or urinary tract cancer surgery. About 992 people will get either standard immunotherapy (nivolumab) or a combination of two immunotherapies (nivolumab and relatlimab) based on their blood …
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New bladder cancer treatment may let patients keep their bladder
Disease control Recruiting nowThis study tests whether a combination of two drugs (enfortumab vedotin and pembrolizumab) can eliminate muscle-invasive bladder cancer so patients can avoid bladder removal. About 47 adults with stage T2-3 bladder cancer will receive the drugs for three cycles, then doctors chec…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Matthew Galsky • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
Bladder cancer patients may avoid surgery with new combo therapy
Disease control Recruiting nowThis study tests whether giving the immunotherapy drug pembrolizumab together with radiation therapy after chemotherapy can help people with muscle invasive bladder cancer keep their bladder instead of having it surgically removed. About 111 participants will receive the combinat…
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:04 UTC
-
New DNA test may spot hidden bladder cancer before surgery
Diagnosis Recruiting nowThis study is testing whether a combination of blood and urine DNA tests can detect muscle-invasive bladder cancer that standard scopes might miss before bladder removal surgery. About 92 adults scheduled for cystectomy will provide samples to see if the test accurately predicts …
Matched conditions: MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Sponsor: Fox Chase Cancer Center • Aim: Diagnosis
Last updated May 26, 2026 09:01 UTC